Attached files

file filename
EX-10.24 - EX-10.24 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex1024.htm
EX-32.1 - EX-32.1 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex321.htm
EX-31.2 - EX-31.2 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex312.htm
EX-31.1 - EX-31.1 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex311.htm
EX-10.26 - EX-10.26 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex1026.htm
EX-10.25 - EX-10.25 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex1025.htm
EX-10.23 - EX-10.23 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex1023.htm
EX-4.2 - EX-4.2 - APPLIED GENETIC TECHNOLOGIES CORPd864197dex42.htm
10-K - 10-K - APPLIED GENETIC TECHNOLOGIES CORPd864197d10k.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

  (1)

Registration Statement (Form S-8 No. 333-198979) pertaining to the Applied Genetic Technologies Corporation 2001 Stock Option Plan, 2011 Stock Incentive Plan, 2013 Equity and Incentive Plan and the 2013 Employee Stock Purchase Plan,

 

  (2)

Registration Statement (Form S-3 No. 333-225286) of Applied Genetic Technologies Corporation, and

 

  (3)

Registration Statement (Form S-8 No. 333-233955) pertaining to the Applied Genetic Technologies Corporation 2013 Equity and Incentive Plan;

of our report dated September 18, 2020, with respect to the financial statements and financial statement schedule of Applied Genetic Technologies Corporation included in this Annual Report (Form 10-K) of Applied Genetic Technologies Corporation for the year ended June 30, 2020.

 

/s/ Ernst & Young LLP
Tampa, Florida
September 18, 2020